Xuefei Shou
Overview
Explore the profile of Xuefei Shou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin B, Ye Z, Cao Z, Ye Z, Yu Y, Jiang W, et al.
Adv Sci (Weinh)
. 2024 Sep;
11(39):e2400684.
PMID: 39225628
Craniopharyngioma (CP) is an intracranial tumor with high mortality and morbidity. Though biologically benign, CP will damage the hypothalamus, inducing comorbidities such as obesity, metabolic syndrome, and cognitive impairments. The...
2.
He W, Yao S, Yu Y, Chen Z, Zhang Q, Qiao N, et al.
Neurosurgery
. 2024 Aug;
96(3):611-621.
PMID: 39171920
Background And Objectives: Silent corticotroph adenoma (SCA) is a high-risk pituitary neuroendocrine tumor (PitNET) which exhibits more aggressive behavior than other nonfunctioning PitNETs. Some SCAs are observed to recur after...
3.
Shen M, Shou X, Chen Z, Ma Z, He W, Zhang Q, et al.
Oper Neurosurg (Hagerstown)
. 2024 Aug;
27(4):455-463.
PMID: 39151069
Background And Objectives: The cavernous internal carotid artery (cICA) and its branches can make it challenging to approach the lateral portion of the retrocarotid area of the cavernous sinus (RcACS)...
4.
Qiao N, Gao W, Deng X, Xin T, Zhang G, Wu N, et al.
Int J Surg
. 2024 Mar;
110(7):4043-4052.
PMID: 38498406
Background: Surgical treatment of complex giant pituitary adenomas (GPAs) presents significant challenges. The efficacy and safety of combining transsphenoidal and transcranial approaches for these tumors remain controversial. In this largest...
5.
Chen Z, Shou X, Ji L, Cheng H, Shen M, Ma Z, et al.
J Clin Endocrinol Metab
. 2024 Jan;
109(6):1433-1442.
PMID: 38163969
Objective: To review experience regarding the treatment of prolactinomas by endoscopic endonasal surgery focusing on the association between presurgical dopamine agonist (DA) treatment and perioperative outcomes, surgical morbidities, endocrine outcomes,...
6.
Shen M, Shou X, Wang Y
Acta Neurochir (Wien)
. 2023 Oct;
165(12):4125-4129.
PMID: 37851167
Background: Direct access to the sphenoid lateral recess offers the best chance of sealing spontaneous cerebrospinal fluid (CSF) rhinorrhea caused by lateral sphenoid encephaloceles of the Sternberg canal defect. Method:...
7.
Zhao J, Ji C, Cheng H, Ye Z, Yao B, Shen M, et al.
J Pathol Clin Res
. 2023 Sep;
9(6):488-497.
PMID: 37661840
Studies describing the clinical presentation and prognosis of patients with silent PIT1 (pituitary specific transcription factor)-lineage pituitary neuroendocrine tumors (PitNETs) are rare. We identified patients with positive PIT1 tumor staining...
8.
Chen J, Jian X, Deng S, Ma Z, Shou X, Shen Y, et al.
Nat Commun
. 2023 Aug;
14(1):5128.
PMID: 37612270
No abstract available.
9.
Shen M, Shou X, Wang Y
Neurosurg Focus Video
. 2023 Jul;
9(1):V6.
PMID: 37416809
MRI-Negative Cushing's disease continues to be a challenging disease despite better imaging and techniques. The situation can be more complicated in the setting of prior surgery or failed surgery. Often,...
10.
Cui Q, Liu X, Sun Q, Sun W, Zheng H, He M, et al.
Endocrine
. 2023 Jun;
81(2):349-356.
PMID: 37284972
Purpose: Patients with Cushing's disease (CD) experienced transient central adrenal insufficiency (CAI) after successful surgery. However, the reported recovery time of hypothalamic-pituitary-adrenal (HPA) axis varied and the related factors which...